Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. It focuses on its product, PCS-499, which is an oral tablet that is a deuterated analog of an active metabolite of an already approved drug. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.
Company profile
Website
CEO
David Young
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Airgate Wireless Inc
SEC CIK
Corporate docs
IRS number
582422929
Latest filings (excl ownership)
RW
Registration withdrawal request
1 Apr 05
15-12G
Securities registration termination
17 Feb 05
10-K/A
2004 FY
Annual report (amended)
15 Feb 05
424B3
Prospectus supplement
10 Feb 05
424B3
Prospectus supplement
10 Feb 05
10-Q
2005 Q1
Quarterly report
9 Feb 05
8-K
Airgate PCS, Inc. Announces First Quarter Fiscal 2005 Results
9 Feb 05
425
Business combination disclosure
7 Feb 05
425
Business combination disclosure
7 Feb 05
425
Business combination disclosure
1 Feb 05
Latest ownership filings
144
Notice of proposed sale of securities
23 Dec 04
144
Notice of proposed sale of securities
23 Dec 04
144
Notice of proposed sale of securities
23 Dec 04
144
Notice of proposed sale of securities
23 Dec 04
144
Notice of proposed sale of securities
23 Dec 04
144
Notice of proposed sale of securities
23 Dec 04
144
Notice of proposed sale of securities
23 Dec 04